Erste Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
Erste Asset Management's NVAX Position: Q3 2021 in Review
Erste Asset Management sold out of Novavax (NVAX) in Q3 2021, closing a stake of 17,600 shares — an estimated $3.68M sold.
Erste Asset Management first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $5.11M in Q1 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.
- Erste Asset Management reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
- Erste Asset Management sold 17,600 Novavax shares in Q3 2021, an estimated $3.68M.
- Erste Asset Management first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
- Erste Asset Management's Novavax position peaked at $5.11M in Q1 2021.
- 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.
Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.